Zobrazeno 1 - 10
of 281
pro vyhledávání: '"Fenwarth, L."'
Autor:
Klos C; CHU Lille, Institute of Medical Genetics, Jeanne de Flandre Hospital, Avenue Eugène Avinée, 59037, Lille Cedex, France., Roynard P; CHU Lille, Institute of Medical Genetics, Jeanne de Flandre Hospital, Avenue Eugène Avinée, 59037, Lille Cedex, France., Berthon C; Hematology Department, CHU Lille, Lille, France.; Plasticity and Resistance to Therapies, University of Lille, CNRS, Inserm, CHU Lille, IRCL, UMR9020 - UMR1277 - Canther - Cancer Heterogeneity, Lille, France., Soenen V; Laboratory of Hematology, CHU Lille, Lille, France., Marceau A; Laboratory of Hematology, CHU Lille, Lille, France., Fournier E; Laboratory of Hematology, CHU Lille, Lille, France., Fenwarth L; Plasticity and Resistance to Therapies, University of Lille, CNRS, Inserm, CHU Lille, IRCL, UMR9020 - UMR1277 - Canther - Cancer Heterogeneity, Lille, France.; Laboratory of Hematology, CHU Lille, Lille, France., Daudignon A; CHU Lille, Institute of Medical Genetics, Jeanne de Flandre Hospital, Avenue Eugène Avinée, 59037, Lille Cedex, France.; Laboratory of Hematology, CH Valenciennes, Valenciennes, France., Roche C; CHU Lille, Institute of Medical Genetics, Jeanne de Flandre Hospital, Avenue Eugène Avinée, 59037, Lille Cedex, France.; Plasticity and Resistance to Therapies, University of Lille, CNRS, Inserm, CHU Lille, IRCL, UMR9020 - UMR1277 - Canther - Cancer Heterogeneity, Lille, France., Guermouche H; CHU Lille, Institute of Medical Genetics, Jeanne de Flandre Hospital, Avenue Eugène Avinée, 59037, Lille Cedex, France. helene.guermouche@chu-lille.fr.
Publikováno v:
Annals of hematology [Ann Hematol] 2024 Nov; Vol. 103 (11), pp. 4793-4795. Date of Electronic Publication: 2024 Aug 29.
Autor:
Joudinaud R; Hematology Laboratory, Centre Hospitalier Universitaire (CHU) de Lille, Lille, France, Lille, France., Boudry A; Laboratory of hematology Lille University hospital, Lille, France., Fenwarth L; CHU Lille, Lille, France., Geffroy S; CHU Lille, Lille, France., Salson M; Univ. Lille, CNRS, Centrale Lille, UMR 9189 CRIStAL, F-59000 Lille, France, Villeneuve d'Ascq, France., Dombret H; Université Paris Cité, Hôpital Saint-Louis, Assistance Publique - Hôpitaux de Paris (AP-HP), Paris, France., Berthon C; CHRU Lille Maladies du sang, lille, France., Pigneux A; Hopital haut leveque, Pessac, France., Lebon D; CHU Amiens, Amiens, France., Peterlin P; Nantes University Hospital, NANTES, France., Bouzy S; Nantes University Hospital, Nantes, France., Flandrin-Gresta P; University Hospital of Saint-Etienne, Saint-Etienne, France., Tavernier E; CHU Saint Etienne, Saint Priest en Jarez, France., Carre M; chu grenoble, GRENOBLE, France., Tondeur S; Grenoble Alpes University, Institute for Advanced Biosciences (INSERM U1209, CNRS UMR 5309), University Hospital, Grenoble, France., Haddaoui L; FILO Tumor Bank, Paris, France., Itzykson RA; Hopital Saint-Louis, Paris, France., Bertoli S; CHU de Toulouse, Centre de Recherches en Cancérologie de Toulouse, Institut Universitaire du Cancer de Toulouse-Oncopole, Université de Toulouse 3 Paul Sabatier, Toulouse, Florida, France., Bidet A; CHU Bordeaux, Pessac, France., Delabesse E; University hospital of Toulouse, university of Toulouse 3, Center of Research on Cancer of Toulouse, Toulouse, France., Hunault M; CHU, Angers, France., Récher C; CHU de Toulouse, Toulouse, France., Preudhomme C; chru of Lille, Lille, France., Duployez N; CHU Lille, Lille, France., Dumas PY; CHU Bordeaux, Service d'Hématologie Clinique et Thérapie cellulaire, F-33000, Bordeaux, France, PESSAC, France.
Publikováno v:
Blood advances [Blood Adv] 2024 Oct 17. Date of Electronic Publication: 2024 Oct 17.
Autor:
Díez-Campelo M; Department of Hematology, Hospital Universitario de Salamanca, Salamanca, Spain; IBSAL, Instituto de investigación Biomédica de Salamanca, Salamanca, Spain. Electronic address: mdiezcampelo@usal.es., López-Cadenas F; Department of Hematology, Hospital Universitario de Salamanca, Salamanca, Spain; IBSAL, Instituto de investigación Biomédica de Salamanca, Salamanca, Spain., Xicoy B; Department of Clinical Hematology, Institut Català d'Oncologia, Hospital Germans Trias i Pujol, Barcelona, Spain; Josep Carreras Leukemia Research Institute, Myeloid Neoplasm Group Universitat Autònoma de Barcelona, Barcelona, Spain., Lumbreras E; IBSAL, Instituto de investigación Biomédica de Salamanca, Salamanca, Spain., González T; IBSAL, Instituto de investigación Biomédica de Salamanca, Salamanca, Spain., Del Rey González M; IBSAL, Instituto de investigación Biomédica de Salamanca, Salamanca, Spain., Sánchez-García J; Department of Hematology, Hospital Universitario Reina Sofía, Córdoba, Spain; Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain; Universidad de Córdoba, Córdoba, Spain., Coll Jordà R; Department of Hematology, Hospital Josep Trueta, Institut Català d'Oncologia, Girona, Spain., Slama B; Department of Clinical Hematology, CH Avignon, Avignon, France., Hernández-Rivas JÁ; Department of Hematology, Hospital Universitario Infanta Leonor, Universidad Complutense de Madrid, Madrid, Spain., Thepot S; Department of Clinical Hematology, Angers University Hospital, Angers, France., Bernal T; Department of Hematology, Hospital Universitario Central de Asturias, Oviedo, Spain., Guerci-Bresler A; Department of Hematology, CHRU Brabois, Vandoeuvre lès Nancy, France., Bargay J; Department of Hematology, Hospital Universitario Son Llatzer, Palma de Mallorca, Spain; Institut d'Investigacio Illes Balears (IdISBa), Palma de Mallorca, Spain., Amigo ML; Department of Hematology, Hospital Universitario Jose María Morales Meseguer, Murcia, Spain., Preudhomme C; Cancer Heterogeneity Plasticity and Resistance to Therapies (CANTHER), UMR9020-U1277, University of Lille, Lille, France; Laboratory of Hematology, CHU Lille, Lille, France., Fenwarth L; Cancer Heterogeneity Plasticity and Resistance to Therapies (CANTHER), UMR9020-U1277, University of Lille, Lille, France; Laboratory of Hematology, CHU Lille, Lille, France., Platzbecker U; Department for Hematology, Cell Therapy, Hemostaseology, and Infectious Medicine, University Hospital Leipzig, Leipzig, Germany., Götze KS; Department of Medicine III, Technical University of Munich, Munich, Germany., Arar A; Department of Hematology, CHR Orleans, Orléans, France., Toribio S; IBSAL, Instituto de investigación Biomédica de Salamanca, Salamanca, Spain., Del Cañizo C; Department of Hematology, Hospital Universitario de Salamanca, Salamanca, Spain; IBSAL, Instituto de investigación Biomédica de Salamanca, Salamanca, Spain., Hernández-Rivas JM; Department of Hematology, Hospital Universitario de Salamanca, Salamanca, Spain; IBSAL, Instituto de investigación Biomédica de Salamanca, Salamanca, Spain; Department of Medicine, University of Salamanca, Salamanca, Spain., Fenaux P; Département (DMU) d'hématologie et immunologie, Service d'hématologie Seniors, Hôpital St Louis, Université de Paris, APHP Nord Paris, France.
Publikováno v:
The Lancet. Haematology [Lancet Haematol] 2024 Sep; Vol. 11 (9), pp. e659-e670. Date of Electronic Publication: 2024 Jul 18.
Autor:
Halik A; Department of Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Tilgner M; Department of Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Silva P; Department of Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Estrada N; Department of Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Altwasser R; Department of Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Jahn E; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Heuser M; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.; Department of Internal Medicine IV, University Hospital Halle (Saale), Martin-Luther-University Halle-Wittenberg, Halle, Germany., Hou HA; Division of Hematology, Department of Internal Medicine, and Division of General Medicine, Department of Internal Medicine, National Taiwan University Hospital, No. 7, Chung Shan South Road, Taipei City, Taiwan., Pratcorona M; Hospital de la Santa Creu i Sant Pau. Institut de Recerca Sant Pau. Department of Medicine, Universitat Autonoma of Barcelona, Barcelona, Spain., Hills RK; Nuffield Department of Population Health, University of Oxford, Oxford, UK., Metzeler KH; Department of Hematology, Cell Therapy, Hemostaseology and Infectious Diseases, University Hospital Leipzig, Leipzig, Germany., Fenwarth L; Unité Mixte de Recherche (UMR) 9020-UMR1277, Canther-Cancer Heterogeneity, Plasticity and Resistance to Therapies, University of Lille, Centre National de la Recherche Scientifique (CNRS), INSERM, Centre Hospitalo-Universitaire (CHU) Lille, Institut de Recherche sur le Cancer de Lille (IRCL), Lille, France., Dolnik A; Department of Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Terre C; Laboratoire de Cytogénétique, Service de Biologie, CH de Versailles, Le Chesnay, France., Kopp K; Department of Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Blau O; Department of Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Szyska M; Department of Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Christen F; Department of Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Krönke J; Department of Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; German Cancer Consortium (Deutsches Konsortium Für Translationale Krebsforschung, DKTK), Partner Site, Berlin, Germany., Vasseur L; Hematology Department, Saint Louis Hospital, AP-HP, Paris, France., Löwenberg B; Department of Hematology, Erasmus MC Cancer Institute, and Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands., Esteve J; Hematology Department, IDIBAPS, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain., Valk PJM; Department of Hematology, Erasmus MC Cancer Institute, and Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands., Duchmann M; Institut de Recherche Saint-Louis (IRSL), Institut National de la Santé et de la Recherche Médicale (INSERM) U944, Centre National de la Recherche Scientifique (CNRS) UMR 7212 GenCellDis, Université Paris Cité, Paris, France., Chou WC; Division of Hematology, Department of Internal Medicine, and Division of General Medicine, Department of Internal Medicine, National Taiwan University Hospital, No. 7, Chung Shan South Road, Taipei City, Taiwan., Linch DC; Department of Haematology, University College London Cancer Institute, London, UK., Döhner H; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Gale RE; Department of Haematology, University College London Cancer Institute, London, UK., Döhner K; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Bullinger L; Department of Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; German Cancer Consortium (Deutsches Konsortium Für Translationale Krebsforschung, DKTK), Partner Site, Berlin, Germany., Yoshida K; Division of Cancer Evolution, National Cancer Center Research Institute, Tokyo, Japan., Damm F; Department of Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany. frederik.damm@charite.de.; German Cancer Consortium (Deutsches Konsortium Für Translationale Krebsforschung, DKTK), Partner Site, Berlin, Germany. frederik.damm@charite.de.
Publikováno v:
Journal of hematology & oncology [J Hematol Oncol] 2024 Aug 19; Vol. 17 (1), pp. 70. Date of Electronic Publication: 2024 Aug 19.
Autor:
Fenwarth L, Duployez N
Publikováno v:
Oncotarget [Oncotarget] 2024 Jun 20; Vol. 15, pp. 400-401. Date of Electronic Publication: 2024 Jun 20.
Autor:
Hirsch P; Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine, CRSA, AP-HP, SIRIC CURAMUS, Hôpital Saint-Antoine, Service d'Hématologie Biologique, 75012, Paris, France. Pierre.hirsch@aphp.fr., Lambert J; Biostatistics and Medical Information Department, Hôpital Saint Louis, Paris, France.; INSERM U1153 - ECSTRRA Team, Hôpital Saint Louis, Paris, France., Bucci M; Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France., Deswarte C; Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine, CRSA, AP-HP, SIRIC CURAMUS, Hôpital Saint-Antoine, Service d'Hématologie Biologique, 75012, Paris, France., Boudry A; Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France., Lambert J; Service d'Hématologie Clinique, André Mignot Hospital, Le Chesnay, France., Fenwarth L; Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France., Micol JB; Gustave Roussy, Université Paris-Saclay, Villejuif, France., Terré C; Laboratory of Hematology, André Mignot Hospital, Le Chesnay, France., Celli-Lebras K; ALFA Group, Paris, France., Thomas X; Lyon Sud, University Hospital, 69495 Pierre-Bénite, Lyon, France., Dombret H; Département Hématologie et Immunologie, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, F-75010, Paris, France., Duployez N; Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France., Preudhomme C; Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France., Itzykson R; Département Hématologie et Immunologie, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, F-75010, Paris, France.; Université Paris Cité, Génomes, biologie cellulaire et thérapeutique U944, INSERM, CNRS, F-75010, Paris, France., Delhommeau F; Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine, CRSA, AP-HP, SIRIC CURAMUS, Hôpital Saint-Antoine, Service d'Hématologie Biologique, 75012, Paris, France.
Publikováno v:
Blood cancer journal [Blood Cancer J] 2024 Jun 13; Vol. 14 (1), pp. 97. Date of Electronic Publication: 2024 Jun 13.
Autor:
Groh M; Department of Internal Medicine, French National Reference Center for Hypereosinophilic syndromes (CEREO), Hôpital Foch, Suresnes, France.; University of Lille, INSERM 1286 INFINITE, CHU de Lille, Lille, France., Fenwarth L; Laboratoire d'Hématologie, Centre de Biologie Pathologie Génétique, CHU Lille, Lille, France., Labro M; Département de Statistiques, Délégation de la recherche clinique et de l'innovation, Hôpital Foch, Suresnes, France., Boudry A; Laboratoire d'Hématologie, Centre de Biologie Pathologie Génétique, CHU Lille, Lille, France., Fournier E; Laboratoire d'Hématologie, Centre de Biologie Pathologie Génétique, CHU Lille, Lille, France., Wemeau M; Département d'Hématologie, CH de Roubaix, Roubaix, France., Marceau-Renaut A; Laboratoire d'Hématologie, Centre de Biologie Pathologie Génétique, CHU Lille, Lille, France., Daltro de Oliveira R; Centre d'Investigations Cliniques, Hôpital Saint-Louis, Hôpital St Louis, AP-HP, Paris, France., Abraham J; Service d'Hématologie Clinique et Thérapie Cellulaire, CHU Limoges, Limoges, France., Barry M; Département d'Hématologie, CH de Boulogne-sur-Mer, Boulogne-sur-Mer, France., Blanche P; Département de Médecine Interne, Hôpital Cochin, AP-HP, Paris, France., Bodard Q; Département de Médecine Interne, CH d'Angoulême, Angoulême, France., Braun T; Département d'Hématologie, Hôpital Avicenne, AP-HP, Paris, France., Chebrek S; Département d'Hématologie, CH d'Avignon, Avignon, France., Decamp M; Service de Génétique, CHU de Caen, Caen, France., Durel CA; Département de Médecine Interne, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France., Forcade E; Département d'Hématologie, CHU de Bordeaux, Bordeaux, France., Gerfaud-Valentin M; Département de Médecine Interne, Hôpital de la Croix Rousse, Hospices Civils de Lyon, Lyon, France., Golfier C; Département d'Hématologie, Hôpital Lyon Sud, Hospices Civils de Lyon, Lyon, France., Gourguechon C; Département d'Hématologie Clinique et Thérapie Cellulaire, CHU Amiens-Picardie, Amiens, France., Grardel N; Laboratoire d'Hématologie, Centre de Biologie Pathologie Génétique, CHU Lille, Lille, France., Kosmider O; Service d'Hématologie Biologique, Centre-Université de Paris, Hôpital Cochin, AP-HP, Paris, France., Martis N; Département de Médecine Interne, CHU de Nice, Université Côte d'Azur, Nice, France., Melboucy Belkhir S; Département de Médecine Interne, CH de St Quentin, St Quentin, France., Merabet F; Département d'Hématologie, CH de Versailles, Le Chesnay, France., Michon A; Département de Médecine Interne, Hôpital Européen Georges-Pompidou, AP-HP, Paris, France., Moreau S; Service d'Hématologie Clinique et Thérapie Cellulaire, CHU Limoges, Limoges, France., Morice C; Service de Dermatologie, CHU de Caen, Caen, France., Néel A; Service de Médecine Interne, CHU de Nantes, Nantes, France., Nicolini FE; Département d'Hématologie, INSERM U 1052, CRCL, Centre Léon Bérard, Lyon, France., Pascal L; Département d'Hématologie, Hôpital St Vincent de Paul, Lille, France., Pasquier F; Département d'Hématologie, Gustave Roussy Cancer Campus, Villejuif, France., Pieragostini A; Département d'Hématologie, CHU de Dijon, Dijon, France., Roche-Lestienne C; Institut de Génétique, Hôpital Jeanne de Flandre, CHU Lille, Lille, France., Rousselot P; Département d'Hématologie, CH de Versailles, Le Chesnay, France., Terriou L; Université de Lille, CHU Lille, Département de Médecine Interne et Immunologie Clinique, Centre de Référence des Maladies Auto-immunes Systémiques Rares du Nord et Nord-Ouest de France (CeRAINO), Lille, France., Thiebaut-Bertrand A; Département d'Hématologie, CHU de Grenoble, Grenoble, France., Viallard JF; Département de Médecine Interne, CHU de Bordeaux, Bordeaux, France., Preudhomme C; Laboratoire d'Hématologie, Centre de Biologie Pathologie Génétique, CHU Lille, Lille, France., Kahn JE; Department of Internal Medicine, Université Paris-Saclay, CHU Ambroise Paré, Boulogne Billancourt Cedex, France.; INSERM UMR1173, Université de Versailles St-Quentin-en-Yvelines, Infection et Inflammation, Montigny-le-Bretonneux, France., Lefevre G; University of Lille, INSERM 1286 INFINITE, CHU de Lille, Lille, France.; Laboratoire d'immunologie, CHU Lille, Lille, France., Duployez N; Laboratoire d'Hématologie, Centre de Biologie Pathologie Génétique, CHU Lille, Lille, France.
Publikováno v:
American journal of hematology [Am J Hematol] 2024 Jun; Vol. 99 (6), pp. 1108-1118. Date of Electronic Publication: 2024 Apr 02.
Autor:
Strullu M; Hématologie et immunologie pédiatrique, hôpital Robert-Debré, GHU AP-HP Nord-Université Paris Cité, Paris, France; Inserm UMR_S1131, Institut universitaire d'hématologie, université Paris Cité, Paris cité, Paris, France. Electronic address: marion.strullu@aphp.fr., Cousin E; Service d'onco-hématologie pédiatrique, CHU de Rennes, Rennes, France., de Montgolfier S; Aix Marseille université, Inserm, IRD, SESSTIM, sciences économiques & sociales de la santé & traitement de l'information médicale, ISSPAM, Marseille, France., Fenwarth L; Département de génétique clinique, laboratoire d'hématologie, unité de génétique moléculaire des hémopathies malignes, CHU de Lille, université de Lille, Lille, France., Gachard N; Laboratoire d'hématologie, CHU de Dupuytren, Limoges, France., Arnoux I; Laboratoire d'hématologie, CHU de Timone, Marseille, France., Duployez N; Laboratoire d'hématologie, unité de génétique moléculaire des hémopathies malignes, CHU de Lille, université de Lille, Lille, France., Girard S; Service d'hématologie biologique, centre de biologie et pathologie Est, LBMMS, hospices civils de Lyon, Lyon, France., Guilmatre A; Service d'hématologie et oncologie pédiatrique, hôpital Armand-Trousseau, AP-HP.Sorbonne Université, Paris, France., Lafage M; CRCM, Inserm UMR1068, CNRS UMR7258, Aix Marseille université U105, laboratoire d'hématologie, CHU Timone, Marseille, France., Loosveld M; CRCM, Inserm UMR1068, CNRS UMR7258, Aix Marseille université U105, laboratoire d'hématologie, CHU Timone, Marseille, France., Petit A; Service d'hématologie et oncologie pédiatrique, hôpital Armand-Trousseau, AP-HP.Sorbonne Université, Paris, France., Perrin L; Génétique clinique, hôpital Robert-Debré, GHU AP-HP Nord-Université Paris cité, Paris, France., Vial Y; Inserm UMR_S1131, Institut universitaire d'hématologie, université Paris Cité, Paris cité, Paris, France; Laboratoire de génétique moléculaire, hôpital Robert-Debré, GHU AP-HP Nord-Université Paris cité, Paris, France., Saultier P; Service d'hématologie immunologie oncologie pédiatrique, Inserm, INRAe, C2VN, hôpital d'Enfants de la Timone, Aix Marseille université, AP-HM, Marseille, France.
Publikováno v:
Bulletin du cancer [Bull Cancer] 2024 Mar; Vol. 111 (3), pp. 291-309. Date of Electronic Publication: 2024 Jan 23.
Autor:
Iat A; Hematology department, Nice University Hospital, Nice, France., Loschi M; Hematology department, Nice University Hospital, Nice, France.; Mediterranean Center of Molecular Medecine, INSERM, Nice, France.; Cote d'Azur University, Nice, France., Benachour S; Hematology department, Nice University Hospital, Nice, France., Calleja A; Hematology department, Nice University Hospital, Nice, France., Chiche E; Hematology department, Nice University Hospital, Nice, France.; Cote d'Azur University, Nice, France., Sudaka I; Hematology Laboratory, Nice University Hospital, Nice, France., Aquaronne D; Hematology Laboratory, Nice University Hospital, Nice, France., Ferrero C; Hematology Laboratory, Nice University Hospital, Nice, France., Fenwarth L; Hematology Laboratory, Lille University Hospital, Lille, France., Marceau A; Hematology Laboratory, Lille University Hospital, Lille, France., Fournier E; Hematology Laboratory, Lille University Hospital, Lille, France., Dadone-Montaudie B; Cote d'Azur University, Nice, France.; Molecular Laboratory, Nice University Hospital, Nice, France., Cluzeau T; Hematology department, Nice University Hospital, Nice, France.; Mediterranean Center of Molecular Medecine, INSERM, Nice, France.; Cote d'Azur University, Nice, France.
Publikováno v:
Cancer medicine [Cancer Med] 2024 Mar; Vol. 13 (6), pp. e7103.
Autor:
Georgi JA; Medizinische Klinik und Poliklinik 1, Medizinische Fakultät und Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Stasik S; Medizinische Klinik und Poliklinik 1, Medizinische Fakultät und Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Kramer M; AvenCell Europe GmbH, Dresden, Germany., Meggendorfer M; MLL Münchner Leukämielabor GmbH, Munich, Germany., Röllig C; Medizinische Klinik und Poliklinik 1, Medizinische Fakultät und Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Haferlach T; MLL Münchner Leukämielabor GmbH, Munich, Germany., Valk P; Erasmus University Medical Center, Rotterdam, Netherlands., Linch D; Department of Haematology, UCL Cancer Institute, London, UK., Herold T; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany., Duployez N; Institut de Recherche contre le Cancer de Lille, Centre Hospitalier Universitaire de Lille, Lille, France., Taube F; Medizinische Klinik und Poliklinik 1, Medizinische Fakultät und Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Middeke JM; Medizinische Klinik und Poliklinik 1, Medizinische Fakultät und Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Platzbecker U; Klinik und Poliklinik fur Hämatologie, Zelltherapie und Hämostaseologie, Universitätsklinikum Leipzig, Leipzig, Germany., Serve H; Medizinische Klinik 2, Universitätsklinikum Frankfurt, Frankfurt am Main, Germany., Baldus CD; Klinik für Innere Medizin II, Universitätsklinikum Schleswig-Holstein, Kiel, Germany., Muller-Tidow C; Klinik für Hämatologie, Onkologie und Rheumatologie, Universitätsklinikum Heidelberg, Heidelberg, Germany., Haferlach C; MLL Münchner Leukämielabor GmbH, Munich, Germany., Koch S; MLL Münchner Leukämielabor GmbH, Munich, Germany., Berdel WE; Department of Medicine A, University Hospital Münster, Münster, Germany., Woermann BJ; German Society of Hematology and Oncology, Berlin, Germany., Krug U; Department of Medicine 3, Klinikum Leverkusen, Leverkusen, Germany., Braess J; Department of Oncology and Hematology, Hospital Barmherzige Brüder, Regensburg, Germany., Hiddemann W; Department of Medicine III, University Hospital LMU Munich, Munich, Germany., Spiekermann K; Department of Medicine III, University Hospital LMU Munich, Munich, Germany., Boertjes EL; Erasmus University Medical Center, Rotterdam, Netherlands., Hills RK; Nuffield Department of Population Health, Oxford University, Oxford, UK., Burnett A; Department of Haematology, Cardiff University, University Hospital of Wales, Cardiff, UK., Ehninger G; AvenCell Europe GmbH, Dresden, Germany., Metzeler K; Klinik und Poliklinik fur Hämatologie, Zelltherapie und Hämostaseologie, Universitätsklinikum Leipzig, Leipzig, Germany., Rothenberg-Thurley M; Department of Medicine III, University Hospital LMU Munich, Munich, Germany., Dufour A; Department of Medicine III, University Hospital LMU Munich, Munich, Germany., Dombret H; Hôpital Saint-Louis (AP-HP), EA 3518, Université de Paris, Paris, France., Pautas C; Service d'Hématologie et de thérapie cellulaire, Hôpital Henri Mondor, Créteil, France., Preudhomme C; Institut de Recherche contre le Cancer de Lille, Centre Hospitalier Universitaire de Lille, Lille, France., Fenwarth L; Institut de Recherche contre le Cancer de Lille, Centre Hospitalier Universitaire de Lille, Lille, France., Bornhäuser M; Medizinische Klinik und Poliklinik 1, Medizinische Fakultät und Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; Nationales Zentrum für Tumorerkrankungen (NCT), Dresden, Germany., Gale R; Department of Haematology, UCL Cancer Institute, London, UK., Thiede C; Medizinische Klinik und Poliklinik 1, Medizinische Fakultät und Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany. christian.thiede@uniklinikum-dresden.de.; AgenDix GmbH, Dresden, Germany. christian.thiede@uniklinikum-dresden.de.
Publikováno v:
Leukemia [Leukemia] 2024 Feb; Vol. 38 (2), pp. 281-290. Date of Electronic Publication: 2024 Jan 16.